5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Aarti Pharmalabs Ltd.

•
aartipharmalabs.comBSE: 543748NSE: AARTIPHARM
Market Cap₹ 7,516 Cr.
Current Price
High / Low₹ 946 / 585
Stock P/E35.3
Book Value₹ 242
Price to Book2.52
Dividend Yield0.42 %
ROCE10.8 %
ROE8.5 %
Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has consistently been profitable over the last 5 years
  • Latest quarter profit grew 53.8% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.22x)
  • Working capital cycle has improved - days down from 115 to 92
  • Company maintains a comfortable, low leverage position

CONS

  • Recent results are weak - TTM profit is down 21.7% versus prior year
  • Promoter holding has decreased over last 2 years: -3.6pp
  • Receivables are growing faster than sales - a possible quality concern
  • Total debt has risen sharply - up 73.0% year on year

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY MICROCAP250NIFTY TOTAL MKT
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.AARTIPHARM828.8535.267516.000.4276.1453.82535.8038.7410.7726.78
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
458440449506555458538564386418432583536
373352353388459364409421291344330470443
Operating Profit8588961189694129143957510211393
OPM %18.52%20.01%21.32%23.24%17.36%20.45%23.91%25.39%24.66%17.86%23.67%19.42%17.40%
0112245120-380
Interest444556107711131713
Depreciation17181919202123232325292830
Profit before Tax64677496747210111567395876101
Tax %26.38%22.61%28.53%31.85%24.73%23.90%26.47%22.93%23.72%27.38%25.73%26.99%24.66%
Net Profit0000555574885028486176
5.205.725.827.206.126.038.169.755.463.085.296.748.40

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
01,2001,9451,8532,1151,8191,969
09951,6031,4671,6511,4501,586
Operating Profit-0205342386464369383
OPM %—17.11%17.58%20.84%21.96%20.29%19.47%
04251075
Interest0122117274753
Depreciation042637387104112
Profit before Tax-0155261300361233275
Tax %-0.00%21.32%25.80%27.82%24.48%24.99%25.92%
Net Profit-0122193217272175203
EPS-0.1813.4921.3523.9330.0619.27—
Dividend Payout %0.00%0.00%9.37%12.53%16.64%18.16%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
-2%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
-3%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
25%
1 Year:
-9%

RETURN ON EQUITY

10 Years:
—
5 Years:
14%
3 Years:
12%
Last Year:
9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Sep 15

₹ 0.40

Rs.2.0000 per share(40%)Final Dividend

2026

Feb 16

₹ 0.30

Rs.1.5000 per share(30%)Interim Dividend

2025

Sep 15

₹ 0.50

Rs.2.5000 per share(50%)Final Dividend

2025

Feb 14

₹ 0.50

Rs.2.5000 per share(50%)Interim Dividend

2024

Jul 31

₹ 0.20

Rs.1.0000 per share(20%)Final Dividend

2024

Feb 16

₹ 0.40

Rs.2.0000 per share(40%)Interim Dividend

2023

Jan 17

₹ 0.40

2026

Aug 18

₹ 0.40

20/10/2026 Equity Rs.2.0000 per share(40%)Final Dividend

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital045454545
1,3411,5131,7111,9432,076
340214281416734
Trade Payables215340378278335
144132166221291
Total Liabilities2,0402,2442,5822,9023,482
7829261,0331,1371,437
Capital Work in Progress1656278307305
328710777194
475602643588640
00519575583
Cash & Bank831224910
502555177211312
Total Assets2,0402,2442,5822,9023,482

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
0-23312216330262
Cash from Investing0-139-158-215-412-431
Cash from Financing0260-1631065171
078-7112-172

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
46.4646.1044.6644.2943.7242.8843.1043.0842.86
7.077.388.647.367.348.027.688.398.17
11.4611.3510.367.527.806.957.667.407.21
0.010.010.010.010.010.010.010.010.01
35.0035.1636.3340.8241.1242.1341.5441.1141.75

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-02
General Updates

2026-09-02 - Aarti Pharmalabs Limited has informed the Exchange about General Updates

2026-08-31
Resignation of Director/KMP/SMP

2026-08-31 - Aarti Pharmalabs Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-31
Change in Management

2026-08-31 - Aarti Pharmalabs Limited has informed the Exchange about change in Management

2026-08-30
Copy of Newspaper Publication

2026-08-30 - Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-29
Updates

2026-08-29 - Aarti Pharmalabs Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'.

2026-08-29
Shareholders meeting

2026-08-29 - Aarti Pharmalabs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026

2026-08-18
Copy of Newspaper Publication

2026-08-18 - Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-17
Record Date

2026-08-17 - Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2026.

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Aarti Pharmalabs Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for AARTIPHARM

Loading news…

🤖

AI Stock Analyst

Aarti Pharmalabs Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login